In soon-to-be published research by Gnosis by Lesaffre, new findings suggest that daily intakes of MenaQ7 vitamin K supplement may improve blood vessel elasticity and regulate blood pressure in menopausal women with arterial stiffness.
A new RCT highlights that following supplementation with vitamin K2 (MK-7) in patients with haemodialysis (HD), there were decreases in measures of arterial stiffness which were more pronounced in those with diabetes, compared to those receiving standard...
A new study testing a methodology for assessing vitamin supplement content has revealed significant deviations in the content of vitamin K2 and D3 in tested supplements, adding that claims made on the labels may be misleading to consumers.
Along with developing the science and marketing story behind an ingredient, suppliers also need to ensure those ingredients are easy to work with. A prominent vitamin K2 supplier says it has done just that with a new, stability-enhanced version of...
Overcoming micronutrient deficiencies could become part of an effective strategy in the fight against COVID-19. While vitamin D supplementation has gained wide attention amid the pandemic, in the shadows is a lesser known but equally important nutrient:...
Norway-based vitamin K2 supplier NattoPharma has highlighted new evidence connecting statin use to increased cardiovascular risk which it says further proves the need for Vitamin K2 supplementation in these patients.
A new study on cardiovascular health using a protein as a biomarker has bolstered the evidence backing the notion that the benefits of vitamin K2 are so important that the substance should have its own RDI, a Norwegian supplier says.
Given the current torrid pace of sales for some categories, the dietary supplement industry could emerge from the present crisis is a significantly strengthened position. Even categories that are in the doldrums stand to benefit.
Researchers found that individuals with arterial stiffening have increased risk of dementia, paving a way to market vitamin K2 in the brain health space—an area in which K2 was not previously considered, according to one supplier.
The United Natural Products Alliance, a trade association for the dietary supplement industry, has signed memoranda of understanding agreements with three single-ingredient associations and their administrative umbrella, the Trust Transparency Center.
There has been a ‘disturbing growth’ in the incidence of low-energy bone fractures in healthy children and adolescents, a group of researchers wrote in a new review, arguing that insufficiency of vitamin D, vitamin K, and calcium are among leading considerations.
It’s fitting that a relatively new institution—Maastricht University—is helping to drive research into the evolving benefits of a ‘new’ vitamin, Vitamin K2. That research will be buoyed by a multi-center EU grant announced today.
Increased intakes of long-chain menaquinones (vitamin K2) may reduce the risk of mortality from coronary heart disease (CHD), according to data from the European Prospective Investigation into Cancer and Nutrition (EPIC-NL) cohort.
After 18 months, DuPont Nutrition & Health and Kappa Bioscience, are set for a large-scale push of synthetic vitamin K2, which has just been approved as a novel food ingredient in the European Union by German authorities.
The null findings of a randomised clinical trial of vitamin K2 and bone health do not mean the vitamin does not benefit skeletal health, say leading scientists in the field who have challenged the recent findings.
Danish supplier Danisco BioActives and Norwegian vitamin K specialist, NattoPharma, have inked a deal that will see Danisco become the marketer and distributor of Natto’s vitamin K2 ingredient to the food industry.